Suppr超能文献

汉族首发未用药的伴亚临床甲状腺功能减退症的重性抑郁障碍患者自杀未遂的相关因素的性别差异:一项横断面研究。

Sex differences in correlates of suicide attempts in Chinese Han first-episode and drug-naïve major depressive disorder with comorbid subclinical hypothyroidism: A cross-sectional study.

机构信息

Institute of Mental Health, Tianjin Anding Hospital, Mental Health Center of Tianjin Medical University, Tianjin, China.

CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China.

出版信息

Brain Behav. 2024 Jun;14(6):e3578. doi: 10.1002/brb3.3578.

Abstract

BACKGROUND

This study aimed to investigate sex differences in risk factors for suicide attempts in first-episode and drug naive (FEDN) major depressive disorder (MDD) with comorbid subclinical hypothyroidism (SCH).

METHODS

A total of 1034 FEDN MDD patients with comorbid SCH were enrolled. The Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), and Positive and Negative Syndrome Scale (PANSS) positive subscale were used to assess patients' symptoms. Thyroid hormone levels and metabolic parameters were measured.

RESULTS

MDD patients with SCH had a significantly higher risk of suicide attempts than those without SCH (25.4% vs. 12.2%). Logistic regression showed that HAMA score, thyroid stimulating hormone (TSH) levels, and thyroid peroxidase antibody (TPOAb) levels were significantly associated with an increased risk for suicide attempts in both male and female MDD patients comorbid SCH, while low-density lipoprotein cholesterol (LDL-C) was significantly associated with an increased risk for suicide attempts only in male patients, HAMD score and systolic blood pressure were significantly associated with an increased risk for suicide attempts only in female patients.

CONCLUSION

SCH comorbidities may increase suicide attempts in MDD patients. Our results showed significant sex differences in clinical and metabolic factors associated with suicide attempts among FEDN MDD patients with comorbid SCH, highlighting appropriate sex-based preventive interventions are needed.

摘要

背景

本研究旨在探讨首发未用药的伴亚临床甲状腺功能减退症(SCH)的重性抑郁障碍(MDD)患者中,自杀未遂的危险因素是否存在性别差异。

方法

共纳入 1034 例首发未用药的伴 SCH 的 MDD 患者。采用汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)和阳性和阴性综合征量表(PANSS)阳性分量表评估患者的症状。检测甲状腺激素水平和代谢参数。

结果

伴 SCH 的 MDD 患者自杀未遂的风险明显高于无 SCH 的患者(25.4% 比 12.2%)。Logistic 回归显示,HAMA 评分、促甲状腺激素(TSH)水平和甲状腺过氧化物酶抗体(TPOAb)水平与伴 SCH 的男女 MDD 患者自杀未遂的风险增加显著相关,而只有男性患者的低密度脂蛋白胆固醇(LDL-C)与自杀未遂风险增加显著相关,HAMD 评分和收缩压仅与女性患者自杀未遂风险增加显著相关。

结论

SCH 合并症可能会增加 MDD 患者的自杀未遂风险。我们的研究结果显示,首发未用药的伴 SCH 的 MDD 患者中,与自杀未遂相关的临床和代谢因素存在显著的性别差异,强调需要针对不同性别进行适当的预防干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f7/11156525/0f17fd83fe3b/BRB3-14-e3578-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验